Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Return on Invested Capital: 2024

  • Adma Biologics' Return on Invested Capital was N/A to 0.51% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.51%, marking a year-over-year change of. This contributed to the annual value of -1.49% for FY2012, which is N/A change from last year.
  • Adma Biologics' Return on Invested Capital amounted to 0.51% in Q3 2024, which was up 14.48% from 0.45% recorded in Q2 2024.
  • Adma Biologics' Return on Invested Capital's 5-year high stood at 0.51% during Q3 2024, with a 5-year trough of 0.45% in Q2 2024.
  • For the 1-year period, Adma Biologics' Return on Invested Capital averaged around 0.48%, with its median value being 0.48% (2024).